Broad and deep expertise in vascular biology and surgery makes our research portfolio one the largest and most diverse of its kind. With over $2.5 million in research expenditures annually, our work is driving discoveries that transform how we understand and treat vascular disease. Whether a relatively common vascular condition, such as venous thrombosis or peripheral artery disease, to rare disorders like fibromuscular dysplasia, our goal is the same: To further our knowledge of vascular biology, disease and surgery so that we can improve clinical care and outcomes for patients worldwide.
Our efforts span basic science and translational, clinical and health services research to medical device development. The impact of our work can be seen in frequently cited faculty publications and recognition with prestigious awards as well as in new approaches, technologies and procedures that are changing clinical practice. Our work also includes novel investigations and development of new and complex image-based cardiovascular models. These models of patient-specific blood flow help our clinicians identify the best approaches for surgical interventions.
Conrad Jobst Vascular Research Laboratories
At the center of our research initiatives is the endowed Conrad Jobst Vascular Research Laboratories, a 4,900-square-foot, state-of-the-art facility that fosters collaboration to speed discovery.
Faculty laboratories within the Jobst Research Laboratories focus on a range of problems, including:
- Identifying new targets for treating venous thrombosis (VT) — responsible for some 300,000 deaths annually in the United States alone — with lower-risk medications
- The role of inflammation and cancer in VT
- The role of e-cigarettes and epigenetics in aneurysm development